%A Coffelt,Seth B. %A Kabelitz,Dieter %A Silva-Santos,Bruno %A Kuball,Jurgen %A Born,Willi %A Bank,Ilan %D 2020 %J Frontiers in Immunology %C %F %G English %K γδ T cells,Cancer,Butyrophilin,Immunotherapy,Bisphoshonates %Q %R 10.3389/fimmu.2020.602411 %W %L %M %P %7 %8 2020-November-20 %9 Editorial %+ Seth B. Coffelt,Institute of Cancer Sciences, University of Glasgow,United Kingdom,seth.coffelt@glasgow.ac.uk %+ Seth B. Coffelt,Cancer Research UK Beatson Institute,United Kingdom,seth.coffelt@glasgow.ac.uk %+ Dieter Kabelitz,Institute of Immunology, University of Kiel,Germany,seth.coffelt@glasgow.ac.uk %+ Prof Bruno Silva-Santos,Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa,Portugal,seth.coffelt@glasgow.ac.uk %+ Jurgen Kuball,Department of Hematology and Center for Translational Immunology, Utrecht Medical Center (UMC),Netherlands,seth.coffelt@glasgow.ac.uk %+ Dr Willi Born,Department of Immunology and Genomic Medicine, National Jewish Health,United States,seth.coffelt@glasgow.ac.uk %+ Ilan Bank,Rheumatology Unit, Division of Medicine, Sheba Medical Center,Israel,seth.coffelt@glasgow.ac.uk %# %! %* %< %T Editorial: γδ T Cells in Cancer %U https://www.frontiersin.org/articles/10.3389/fimmu.2020.602411 %V 11 %0 JOURNAL ARTICLE %@ 1664-3224